A European, Observational, Prospective Trial of Trabectedin Plus Pegylated Liposomal Doxorubicin in Patients with Platinum‐Sensitive Ovarian Cancer

PURPOSE: The noninterventional, prospective NIMES‐ROC phase IV study (NCT02825420) evaluated trabectedin plus pegylated liposomal doxorubicin (PLD) in real‐life clinical practice. PATIENTS AND METHODS: Eligible participants included adults with platinum‐sensitive recurrent ovarian cancer (PS‐ROC) wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Pignata, Sandro, Scambia, Giovanni, Villanucci, Alessandro, Naglieri, Emanuele, Ibarbia, Mikel Arruti, Brusa, Federica, Bourgeois, Hugues, Sorio, Roberto, Casado, Antonio, Reichert, Dietmar, Dopchie, Catherine, De Rivas, Beatriz, de Sande, Luis Miguel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Gynecologic Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018301/
https://www.ncbi.nlm.nih.gov/pubmed/33289956
http://dx.doi.org/10.1002/onco.13630

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018301/
https://www.ncbi.nlm.nih.gov/pubmed/33289956
http://dx.doi.org/10.1002/onco.13630

Ejemplares similares